Healthcare Investment Act
Senate Bill 405, titled the Healthcare Investment Act, is primarily a budget and appropriations measure focused on Medicaid and related Department of Health and Human Services operations. It increases recurring Medicaid funding to account for projected enrollment, service-cost, and federal match changes, and provides additional money for managed care contracts, including implementation of the Children and Families Specialty Plan. The bill also requires local management entities/managed care organizations to make specified intergovernmental transfers to DHHS over the 2025-2027 biennium.
The bill makes several offsetting reductions and reallocations within DHHS and related funds. It reduces single-stream funding for mental health, developmental disabilities, and substance use services, then backfills part of that reduction with transfers from the Opioid Abatement Reserve. It repeals the Prescription Digital Therapeutics Pilot Program and moves money from the Opioid Abatement Fund to the reserve. It also requires DHHS to eliminate vacant positions to achieve recurring savings, reduces funding for the Whole Child Health Section and the Medical Eye Care Program, and directs DHHS to develop and report on Medicaid cost-savings and efficiency measures. In addition, it authorizes the State Auditor to examine Medicaid redetermination efforts in county social services departments and appropriates funds for that audit.
Beyond health and human services, the bill reduces appropriations to Future Building Reserves for state agency building and operating expenses. It also includes standard budget-bill provisions stating that its appropriations and authorizations control over conflicting budget law until the current operations appropriations act for the year becomes law, and it applies retroactively to July 1, 2025 except where otherwise specified.
The overall sentiment reflected in the voting history appears generally favorable, with the bill advancing on second reading in the Senate by a 35-11 vote and later passing a House second reading unanimously, 110-0. That pattern suggests broad support for the bill’s Medicaid funding adjustments and budget rebalancing, even though it contains significant spending reductions and administrative mandates.
The main points of contention are likely the bill’s offsetting cuts and operational constraints rather than the Medicaid funding increase itself. Potentially controversial provisions include the elimination of vacant DHHS positions, reductions to single-stream mental health funding, the use of opioid settlement resources to cover service funding, and the requirement that LME/MCOs maintain service utilization levels without creating a private right of action. The audit of county Medicaid redetermination efforts and the directive to increase DHHS efficiency may also be viewed as oversight measures by supporters and as added administrative pressure by critics.
The bill amends appropriations and budget directives affecting the Department of Health and Human Services, especially the Division of Health Benefits and the Division of Mental Health, Developmental Disabilities, and Substance Use Services. It changes recurring and nonrecurring funding levels, authorizes intergovernmental transfers from LME/MCOs, redirects opioid settlement funds, mandates vacancy eliminations, and requires DHHS planning and reporting on Medicaid cost containment. It also directs the State Auditor to review Medicaid eligibility redeterminations in county DSS offices and reduces funding for Future Building Reserves, thereby altering state budget allocations and the use of certain reserve funds.
The bill appears to have broad legislative support, as shown by strong second-reading votes in both chambers, including unanimous House support in the available voting history. The tone of the bill is pragmatic and budget-focused, emphasizing Medicaid stabilization, program integrity, and cost savings rather than major policy expansion. The absence of recorded committee transcript debate limits insight into detailed floor or committee concerns, but the vote margins suggest the bill was not highly polarizing overall.
Likely areas of disagreement include the tradeoff between increased Medicaid funding and the bill’s offsetting reductions elsewhere in DHHS, especially the cuts to single-stream funding and the elimination of vacant positions. Stakeholders in behavioral health and disability services may object to the reduction in single-stream funding and the reliance on opioid settlement dollars to fill the gap. LME/MCOs may also scrutinize the required intergovernmental transfers and the mandate to maintain service utilization levels, while county social services agencies could be affected by the audit of Medicaid redeterminations. Supporters are likely to frame these provisions as accountability and efficiency measures, while critics may view them as budget cuts that shift pressure onto local systems and service providers.